Texas Administrative Code › Title 25 - HEALTH SERVICES › Part 11 - CANCER PREVENTION AND RESEARCH INSTITUTE OF TEXAS › Chapter 703 - GRANTS FOR CANCER PREVENTION AND RESEARCH › Section 703.7 - Program Integration Committee Funding Recommendation

Current through Reg. 49, No. 28; July 12, 2024
(a) The Institute uses a Program Review process undertaken by the Institute's Program Integration Committee to identify and recommend for funding a final list of meritorious Cancer Research projects, including those projects with Cancer Research Product Development prospects, and evidence-based Cancer Prevention and Control Program projects that are in the best overall interest of the State.
(b) Program Review shall be conducted pursuant to the requirements set forth in Chapter 702 of this title (relating to Institute Standards on Ethics and Conflicts, Including the Acceptance of Gifts and Donations to the Institute) and Chapter  102, Texas Health and Safety Code.
(c) The Program Integration Committee shall meet pursuant to a schedule established by the Chief Executive Officer, who serves as the Committee's presiding officer, to consider the prioritized list of Grant Applications submitted by the Prevention Review Council, the Product Development Review Council, or the Scientific Review Council.
(d) The Program Integration Committee shall approve by a majority vote a final list of Grant Applications recommended for Grant Awards to be provided to the Oversight Committee, including a list of Grant Applications, if any, that have been deferred until a future meeting of the Program Integration Committee. In composing the final list of Grant Applications recommended for Grant Award funding, the Program Integration Committee shall:
(1) Substantially base the list upon the Grant Award recommendations submitted by the Review Council.
(2) To the extent possible, give priority for funding to Grant Applications that:
(A) Could lead to immediate or long-term medical and scientific breakthroughs in the area of Cancer Prevention or cures for cancer;
(B) Strengthen and enhance fundamental science in Cancer Research;
(C) Ensure a comprehensive coordinated approach to Cancer Research and Cancer Prevention;
(D) Are interdisciplinary or interinstitutional;
(E) Address federal or other major research sponsors' priorities in emerging scientific or Technology fields in the area of Cancer Prevention, or cures for cancer;
(F) Are matched with funds available by a private or nonprofit entity and institution or institutions of higher education;
(G) Are collaborative between any combination of private and nonprofit entities, public or private agencies or institutions in this state, and public or private institutions outside this state;
(H) Have a demonstrable economic development benefit to this state;
(I) Enhance research superiority at institutions of higher education in this state by creating new research superiority, attracting existing research superiority from institutions not located in this state and other research entities, or enhancing existing research superiority by attracting from outside this state additional researchers and resources;
(J) Expedite innovation and commercialization, attract, create, or expand private sector entities that will drive a substantial increase in high-quality jobs, and increase higher education applied science or Technology research capabilities; and
(K) Address the goals of the Texas Cancer Plan.
(3) Document the factors considered in making the Grant Award recommendations, including any factors not listed in paragraph (2) of this subsection;
(4) Explain in writing the reasons for not recommending a Grant Application that was recommended for a Grant Award by the Review Council or for deferring a Grant Application recommendation until a future meeting date;
(5) Specify the amount of Grant Award funding for each Grant Application.
(A) Unless otherwise specifically stated, the Program Integration Committee adopts the changes to the Grant Award amount recommended by the Review Council.
(B) If the Program Integration Committee approves a change in the Grant Award amount that was not recommended by the Review Council, then the Grant Award amount and a written explanation for the change shall be provided.
(6) Specify changes, if any, to the Grant Application's Scope of Work recommended for a Grant Award and provide an explanation for the changes made;
(7) Address how the funding recommendations meet the annual priorities for Cancer Prevention, Cancer Research and Product Development programs and affect the Institute's overall Grant Award portfolio established by the Oversight Committee; and
(8) Provide a list of deferred Grant Applications, if any.